Combined use of the ProSeal laryngeal mask airway and a bronchial blocker vs. a double-lumen endobronchial tube in thoracoscopic surgery: A randomized controlled trial

The combined use of the ProSeal laryngeal mask airway and a bronchial blocker may reduce postoperative hoarseness and sore throat. We aimed to test the feasibility and efficacy of this combination technique in thoracoscopic surgery. A single-center, patient-assessor blinded, randomized controlled tr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical anesthesia 2023-09, Vol.88, p.111136-111136, Article 111136
Hauptverfasser: Nakanishi, Toshiyuki, Sento, Yoshiki, Kamimura, Yuji, Nakamura, Ryuji, Hashimoto, Hiroya, Okuda, Katsuhiro, Nakanishi, Ryoichi, Sobue, Kazuya
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The combined use of the ProSeal laryngeal mask airway and a bronchial blocker may reduce postoperative hoarseness and sore throat. We aimed to test the feasibility and efficacy of this combination technique in thoracoscopic surgery. A single-center, patient-assessor blinded, randomized controlled trial. Nagoya City University Hospital (between November 2020 and April 2022). A total of 100 adult patients undergoing lobectomy or segmentectomy by video- or robotic-assisted thoracoscopic surgery. Patients were randomly assigned to either group using a combination of the ProSeal laryngeal mask airway and a bronchial blocker (pLMA+BB group) or a double-lumen endobronchial tube (DLT group). The primary outcome was the hoarseness incidence on 1–3 postoperative days. Secondary outcomes included sore throat, intraoperative complications (hypoxemia, hypercapnia, surgical interruption, malposition of devices, unintended lung expansion, and ventilatory difficulty), lung collapse, device placement-related outcomes, and coughing during emergence. A total of 100 patients underwent randomization (51 to the pLMA+BB group and 49 to the DLT group). After drop outs, a total of 49 patients in each group were analyzed per-protocol. The incidences of hoarseness in the pLMA+BB and DLT groups were 42.9% and 53.1% (difference, −10.2%; 95% confidence interval, −30.1% to 10.3%; p = 0.419), 18.4% vs. 32.7%, and 20.4% vs. 24.5% on postoperative day 1, 2, and 3, respectively. The incidences of sore throat in the pLMA+BB and DLT groups were 16.3% vs. 34.7% (difference, −18.4%; 95% confidence interval, −35.9% to −0.9%; p = 0.063) on postoperative day 1. In the pLMA+BB group, more intraoperative complications and less coughing during emergence were observed compared to the DLT group. Lung collapse and placement-related outcomes were comparable between the groups. The combination of ProSeal laryngeal mask airway and bronchial blocker did not significantly reduce hoarseness compared to the double-lumen endobronchial tube. •Double-lumen endobronchial tubes (DLTs) sometimes cause hoarseness and sore throat.•Little is known about a combination of the LMA ProSeal and a bronchial blocker (pLMA+BB).•We compared pLMA+BB and DLT in a robotic- and video-assisted thoracoscopic surgery.•Postoperative hoarseness and sore throat were comparable between the two groups.•The pLMA+BB was feasible but had more frequent intraoperative complications.
ISSN:0952-8180
1873-4529
DOI:10.1016/j.jclinane.2023.111136